# Phase 15: Baseline Reconciliation

## Objective
Create one authoritative execution baseline before implementation starts: status truth, deduplicated findings, and signed acceptance criteria for all next phases.

## Depends on
- Completed historical context from Phases 1-13

## Milestones

### milestone_15_1: Canonical Backlog Reconciliation
status: done (2026-03-03, PR #793)
- Scope:
  - Merge reviewer findings into one backlog.
  - Deduplicate overlaps and normalize severity (`P0`-`P3`).
  - Tag each item to owning future phase.
- Definition of done:
  - One canonical backlog file exists and is current.
  - No duplicate finding IDs remain.
- Evidence:
  - Canonical backlog: `## Canonical Findings` + `## Deduplication Ledger` sections in this file

### milestone_15_2: Phase Contract Definition
status: done (2026-03-03, PR #794)
- Scope:
  - Define entry/exit criteria for Phases 15-35.
  - Define mandatory local validation expectations for each phase.
- Definition of done:
  - Every phase has explicit completion gates.
  - Every gate maps to at least one concrete validation step.
- Evidence:
  - Phase contract baseline: embedded `## Quality Contract` sections in phase files `15`-`35`

### milestone_15_3: Stakeholder Sign-off Snapshot
status: done (2026-03-03, PR #795)
- Scope:
  - Review reconciled backlog + phase contracts.
  - Record explicit sign-off decision and open risks.
- Definition of done:
  - Sign-off recorded in plan docs.
  - Any deferred risks are linked to backlog issues.
- Evidence:
  - Sign-off snapshot: `## Sign-off Snapshot` section in this file
  - Backlog issue register: `plans/issues/archive/phase15-canonical-backlog-issues.md`

## Canonical Findings

| ID | Title | Severity | Owning Phase | Source(s) | Backlog Issue | Status |
|---|---|---|---|---|---|---|
| `BL-15-001` | Demo sweep evidence must be reproducible via explicit command/script reference | `P2` | Phase 16 | Phase 14 review finding, section 4.2 | [/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-001](/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-001) | open |
| `BL-15-002` | Validation evidence should annotate test-count drift and timing variance to avoid ambiguity in phase closeout artifacts | `P3` | Phase 24 | Phase 14 review findings, sections 2.1 and 4.3 | [/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-002](/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-002) | open |
| `BL-15-003` | Test-only carve-out (`RawCode`/`SynItem`) must remain isolated from production paths with explicit guardrails | `P1` | Phase 20 | Phase 14 review and production-grade review findings | [/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-003](/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-003) | open |
| `BL-15-004` | Production banlist and structured-lowering gates must stay enforced in local-first validation loops | `P1` | Phase 25 | Phase 14 production-grade review findings | [/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-004](/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-004) | open |
| `BL-15-005` | E2E timing budgets need explicit baseline and regression thresholds | `P2` | Phase 29 | Phase 14 production-grade review finding, section 5.3 | [/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-005](/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-005) | open |
| `BL-15-006` | Deferred planning gaps for Phases 36 and 37 require explicit closure criteria before track completion | `P2` | Phase 35 | Historical deferred planning drafts | [/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-006](/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-006) | open |

## Deduplication Ledger

| Duplicate Group | Merged Into | Notes |
|---|---|---|
| `DG-15-001` | `BL-15-002` | Test-count variance and timing variance appeared as separate review notes; normalized as one evidence-quality contract item. |
| `DG-15-002` | `BL-15-003` | Test-only carve-out risk appeared in both review files; retained once with shared source attribution. |

No duplicate canonical IDs remain in this backlog.

## Sign-off Snapshot

Decision: **approved**.

Rationale:
- Canonical backlog exists with deduplicated finding IDs and normalized severity.
- Every phase (`15`-`35`) now has explicit entry/exit criteria.
- Every phase gate maps to explicit validation goals.
- Deferred risks are explicitly tracked and linked to backlog issues.

Recorded authority:
- Repository execution owner workflow instruction for Phase 15 on 2026-03-03.

## Deferred Risks (Linked)
- `BL-15-001` -> [/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-001](/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-001)
- `BL-15-002` -> [/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-002](/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-002)
- `BL-15-003` -> [/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-003](/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-003)
- `BL-15-004` -> [/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-004](/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-004)
- `BL-15-005` -> [/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-005](/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-005)
- `BL-15-006` -> [/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-006](/plans/issues/archive/phase15-canonical-backlog-issues.md#phase15-bl-15-006)

## Quality Contract
- Entry criteria: Phase 14 is completed and phase-review findings are available.
- Exit criteria: Canonical source of truth is approved and locked for execution.
- Milestone quality checks:
  - Every milestone in this phase must satisfy the scope and definition-of-done already documented in this file.
  - Validation evidence must be recorded in the phase execution checklist issue before merge.
  - Validation evidence for every milestone must include at least one positive-path case and one negative-path case mapped to the milestone validation planning goals.
- Validation planning goals:
  - `milestone_15_1` (Canonical Backlog Reconciliation): validation goals cover: Merge reviewer findings into one backlog; Deduplicate overlaps and normalize severity (`P0`-`P3`); Tag each item to owning future phase. Include negative-path goals that catch regressions against these guarantees.
  - `milestone_15_2` (Phase Contract Definition): validation goals cover: Define entry/exit criteria for Phases 15-35; Define mandatory local validation expectations for each phase. Include negative-path goals that catch regressions against these guarantees.
  - `milestone_15_3` (Stakeholder Sign-off Snapshot): validation goals cover: Review reconciled backlog + phase contracts; Record explicit sign-off decision and open risks. Include negative-path goals that catch regressions against these guarantees.
  - Exit-gate evidence explicitly demonstrates: Canonical source of truth is approved and locked for execution.

## Exit Gate
- Canonical source of truth is approved and locked for execution.
